OmniCell, a Mountain View, Calif. provider of medication and supply management solutions and analytics software for healthcare systems, has acquired MTS Medication Technologies, Inc., a provider of medication adherence packaging systems. Omnicell says it will use the MTS Medication acquisition to integrate medication management across a broader spectrum of care.
“Providing medication management solutions across the entire spectrum of healthcare is aligned with the needs of our customers to increase efficiency by reducing recurrences of patient treatment needs,” Randall Lipps, chairman, president and CEO of Omnicell, said in a statement.
MTS’s medication management equipment, software and consumables cater to institutional pharmacy providers, who use it to supply long-term care and non-acute care facilities with single-dose, 30-day blister card medication packages to help nurses adhere to prescribed orders. The company also provides multi-dose adherence packages that aims to help patients and caregivers in the home to manage medication administration, by providing all the doses required at a single administration time in a single package.
MTS Medication Technologies will continue to operate under that brand, as a wholly-owned subsidiary of Omnicell, immediately following the closing of the acquisition.
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.